Depletion of PHLDB2 Suppresses Epithelial–Mesenchymal Transition and Enhances Anti-Tumor Immunity in Head and Neck Squamous Cell Carcinoma. This evidence concerns the gene PHLDB2 and head and neck squamous cell carcinoma.